231 related articles for article (PubMed ID: 8807588)
1. Prostaglandin E1 inhibits collagen expression in anti-thymocyte antibody-induced glomerulonephritis: possible role of TGF beta.
Schneider A; Thaiss F; Rau HP; Wolf G; Zahner G; Jocks T; Helmchen U; Stahl RA
Kidney Int; 1996 Jul; 50(1):190-9. PubMed ID: 8807588
[TBL] [Abstract][Full Text] [Related]
2. Prostaglandin E1 reduces the glomerular mRNA expression of monocyte-chemoattractant protein 1 in anti-thymocyte antibody-induced glomerular injury.
Jocks T; Zahner G; Freudenberg J; Wolf G; Thaiss F; Helmchen U; Stahl RA
J Am Soc Nephrol; 1996 Jun; 7(6):897-905. PubMed ID: 8793799
[TBL] [Abstract][Full Text] [Related]
3. Pentoxifylline attenuates experimental mesangial proliferative glomerulonephritis.
Chen YM; Chien CT; Hu-Tsai MI; Wu KD; Tsai CC; Wu MS; Tsai TJ
Kidney Int; 1999 Sep; 56(3):932-43. PubMed ID: 10469361
[TBL] [Abstract][Full Text] [Related]
4. Extracellular matrix deposition and cell proliferation in a model of chronic glomerulonephritis in the rat.
Harendza S; Schneider A; Helmchen U; Stahl RA
Nephrol Dial Transplant; 1999 Dec; 14(12):2873-9. PubMed ID: 10570090
[TBL] [Abstract][Full Text] [Related]
5. Pharmacologic control of angiotensin II ameliorates renal disease while reducing renal TGF-beta in experimental mesangioproliferative glomerulonephritis.
Zoja C; Abbate M; Corna D; Capitanio M; Donadelli R; Bruzzi I; Oldroyd S; Benigni A; Remuzzi G
Am J Kidney Dis; 1998 Mar; 31(3):453-63. PubMed ID: 9506682
[TBL] [Abstract][Full Text] [Related]
6. Monocyte chemoattractant protein-1 mediates collagen deposition in experimental glomerulonephritis by transforming growth factor-beta.
Schneider A; Panzer U; Zahner G; Wenzel U; Wolf G; Thaiss F; Helmchen U; Stahl RA
Kidney Int; 1999 Jul; 56(1):135-44. PubMed ID: 10411686
[TBL] [Abstract][Full Text] [Related]
7. Increased expression of monocyte chemoattractant protein-1 in anti-thymocyte antibody-induced glomerulonephritis.
Stahl RA; Thaiss F; Disser M; Helmchen U; Hora K; Schlöndorff D
Kidney Int; 1993 Nov; 44(5):1036-47. PubMed ID: 8264133
[TBL] [Abstract][Full Text] [Related]
8. Dynamic expression patterns of transforming growth factor-beta(2) and transforming growth factor-beta receptors in experimental glomerulonephritis.
Hartner A; Hilgers KF; Bitzer M; Veelken R; Schöcklmann HO
J Mol Med (Berl); 2003 Jan; 81(1):32-42. PubMed ID: 12545247
[TBL] [Abstract][Full Text] [Related]
9. Elevated expression of transforming growth factor-beta and proteoglycan production in experimental glomerulonephritis. Possible role in expansion of the mesangial extracellular matrix.
Okuda S; Languino LR; Ruoslahti E; Border WA
J Clin Invest; 1990 Aug; 86(2):453-62. PubMed ID: 2200803
[TBL] [Abstract][Full Text] [Related]
10. Treatment with anti-TGF-beta antibody ameliorates chronic progressive nephritis by inhibiting Smad/TGF-beta signaling.
Fukasawa H; Yamamoto T; Suzuki H; Togawa A; Ohashi N; Fujigaki Y; Uchida C; Aoki M; Hosono M; Kitagawa M; Hishida A
Kidney Int; 2004 Jan; 65(1):63-74. PubMed ID: 14675037
[TBL] [Abstract][Full Text] [Related]
11. Effects of all-trans-retinoic acid (atRA) on inducible nitric oxide synthase (iNOS) activity and transforming growth factor beta-1 production in experimental anti-GBM antibody-mediated glomerulonephritis.
Datta PK; Reddy RS; Lianos EA
Inflammation; 2001 Dec; 25(6):351-9. PubMed ID: 11831438
[TBL] [Abstract][Full Text] [Related]
12. Simvastatin suppresses glomerular cell proliferation and macrophage infiltration in rats with mesangial proliferative nephritis.
Yoshimura A; Inui K; Nemoto T; Uda S; Sugenoya Y; Watanabe S; Yokota N; Taira T; Iwasaki S; Ideura T
J Am Soc Nephrol; 1998 Nov; 9(11):2027-39. PubMed ID: 9808088
[TBL] [Abstract][Full Text] [Related]
13. Modulation of experimental mesangial proliferative nephritis by interferon-gamma.
Johnson RJ; Lombardi D; Eng E; Gordon K; Alpers CE; Pritzl P; Floege J; Young B; Pippin J; Couser WG
Kidney Int; 1995 Jan; 47(1):62-9. PubMed ID: 7731171
[TBL] [Abstract][Full Text] [Related]
14. Transforming growth factor-beta receptors in self-limited vs. chronic progressive nephritis in rats.
Watanabe T; Yamamoto T; Ikegaya N; Fujigaki Y; Suzuki H; Togawa A; Fukasawa H; Nagase M; Hishida A
J Pathol; 2002 Nov; 198(3):397-406. PubMed ID: 12375273
[TBL] [Abstract][Full Text] [Related]
15. The effects of platelet-derived growth factor antagonism in experimental glomerulonephritis are independent of the transforming growth factor-beta system.
Ostendorf T; Kunter U; van Roeyen C; Dooley S; Janjic N; Ruckman J; Eitner F; Floege J
J Am Soc Nephrol; 2002 Mar; 13(3):658-667. PubMed ID: 11856769
[TBL] [Abstract][Full Text] [Related]
16. Effects of retinoids on the TGF-beta system and extracellular matrix in experimental glomerulonephritis.
Morath C; Dechow C; Lehrke I; Haxsen V; Waldherr R; Floege J; Ritz E; Wagner J
J Am Soc Nephrol; 2001 Nov; 12(11):2300-2309. PubMed ID: 11675406
[TBL] [Abstract][Full Text] [Related]
17. Collagen-binding heat shock protein (HSP) 47 expression in anti-thymocyte serum (ATS)-induced glomerulonephritis.
Razzaque MS; Taguchi T
J Pathol; 1997 Sep; 183(1):24-9. PubMed ID: 9370943
[TBL] [Abstract][Full Text] [Related]
18. Administration of IgG Fc fragments prevents glomerular injury in experimental immune complex nephritis.
Gómez-Guerrero C; Duque N; Casado MT; Pastor C; Blanco J; Mampaso F; Vivanco F; Egido J
J Immunol; 2000 Feb; 164(4):2092-101. PubMed ID: 10657663
[TBL] [Abstract][Full Text] [Related]
19. Effect of renovascular hypertension on experimental glomerulonephritis in rats.
Wenzel UO; Thaiss F; Panzer U; Schneider A; Schwietzer G; Helmchen U; Stahl RA
J Lab Clin Med; 1999 Sep; 134(3):292-303. PubMed ID: 10482315
[TBL] [Abstract][Full Text] [Related]
20. Renovascular hypertension does not influence repair of glomerular lesions induced by anti-thymocyte glomerulonephritis.
Wenzel UO; Wolf G; Thaiss F; Helmchen U; Stahl RA
Kidney Int; 2000 Sep; 58(3):1135-47. PubMed ID: 10972677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
